Description

The Cardiac Marker Test YRA363 // YRA367 offers a cutting-edge solution in the field of in vitro diagnostics, focusing on the precise detection of cardiac health markers such as NT-ProBNP and hs-cTnI. Leveraging enzymatic chemiluminescence and featuring alkaline phosphatase as the luminous marker, these kits provide high sensitivity and stability. With its unique magnetic separation technology and compatibility with Chemiluminescence Immunoassay Analyzer models YR06387 and YR06388, this product ensures accurate and reliable results in a seamless, automated manner. Ease of use and minimal handling ensure that tests can be conducted swiftly, thereby optimizing workflow efficiency in laboratories.

Market Price

In the market, cardiac marker test kits such as the YRA363 and YRA367 are typically priced between $300 and $500, depending on suppliers and special features offered. For precise pricing tailored to your needs, we encourage you to request a quotation or use the automatic quotation generation feature available through the Kalstein Plus platform.

Frequently Asked Questions

What parameters are tested with this kit? The YRA363 and YRA367 kits focus on NT-ProBNP and hs-cTnI respectively, essential markers for cardiac health.

Are these kits compatible with existing equipment? Yes, they are designed to be compatible with the YR06387 and YR06388 analyzer models.

How should the kits be stored? The kits should be stored at a temperature between 2-8°C to maintain their efficacy.

Advantages and Disadvantages

A significant advantage of the Cardiac Marker Test kits is their high sensitivity and specificity, ensuring reliable results. The use of sophisticated magnetic separation technology enhances the precision of the assays. Additionally, the kits’ compatibility with automated analyzers reduces manual handling and increases throughput. A potential disadvantage may be the initial investment cost for acquiring compatible analyzers if not already in possession…

Product Use in the Field

The Cardiac Marker Test YRA363 // YRA367 is employed in clinical laboratories and hospitals to assess patients’ cardiac biomarkers. This facilitates timely diagnosis and management of cardiac-related conditions. The kits are used to run multiple tests simultaneously, significantly improving diagnostic throughput and enabling healthcare professionals to make informed, data-driven decisions.

Recommendations

To maximize the efficiency of the Cardiac Marker Test kits, it is advisable to adhere strictly to the manufacturer’s instructions for storage and handling. Regular calibration of analyzers and proper maintenance routines will ensure long-term accuracy and reliability of results. Employing trained personnel to operate the equipment will further reduce the risk of errors.

Features

• High sensitivity and specificity due to enzymatic chemiluminescence.
• Patented magnetic separation technology.
• Compatible with automated system models YR06387 and YR06388.
• Safe for use, eliminating radioactive hazards.
• Offered in kits with varying test capacities (100, 50, or 48 tests per kit).
• ALP (alkaline phosphatase) as the luminous marker.

Technical Specifications